Monia Capponi

1.6k total citations
6 papers, 91 citations indexed

About

Monia Capponi is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Monia Capponi has authored 6 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Monia Capponi's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Monia Capponi is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Monia Capponi collaborates with scholars based in Italy, Lebanon and United States. Monia Capponi's co-authors include Barbara Belfiori, Elisabetta Schiaroli, Franco Baldelli, Daniela Francisci, Leonardo Flenghi, Flavio Falcinelli, Giuseppe Visani, Antonio Tabilio, Alessandro Pulsoni and Mauro Di Ianni and has published in prestigious journals such as Blood Cells Molecules and Diseases, Infection and Hematological Oncology.

In The Last Decade

Monia Capponi

6 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monia Capponi Italy	5	59	55	25	22	18	6	91
Marco Rais Italy	5	57 1.0×	19 0.3×	14 0.6×	19 0.9×	14 0.8×	12	98
Christina Ganesh United States	4	72 1.2×	50 0.9×	20 0.8×	10 0.5×	13 0.7×	5	123
Hannah K. Jackson United Kingdom	5	41 0.7×	39 0.7×	13 0.5×	11 0.5×	9 0.5×	9	105
Vesa Lindström Finland	8	39 0.7×	14 0.3×	23 0.9×	26 1.2×	41 2.3×	13	117
A Kagramanova Russia	6	63 1.1×	8 0.1×	11 0.4×	13 0.6×	28 1.6×	46	108
G.B. Gaeta Italy	4	105 1.8×	133 2.4×	4 0.2×	10 0.5×	5 0.3×	5	146
P. Halfon France	6	119 2.0×	126 2.3×	22 0.9×	7 0.3×	11 0.6×	17	170
G.-P. Pageaux France	2	23 0.4×	39 0.7×	9 0.4×	3 0.1×	14 0.8×	3	84
I. Lecouillard France	5	12 0.2×	19 0.3×	12 0.5×	14 0.6×	20 1.1×	11	67
Jennifer H. Cooperrider United States	5	23 0.4×	43 0.8×	39 1.6×	3 0.1×	53 2.9×	20	123

Countries citing papers authored by Monia Capponi

Since Specialization

Citations

This map shows the geographic impact of Monia Capponi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monia Capponi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monia Capponi more than expected).

Fields of papers citing papers by Monia Capponi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monia Capponi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monia Capponi. The network helps show where Monia Capponi may publish in the future.

Co-authorship network of co-authors of Monia Capponi

This figure shows the co-authorship network connecting the top 25 collaborators of Monia Capponi. A scholar is included among the top collaborators of Monia Capponi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monia Capponi. Monia Capponi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tiacci, Enrico, Luca De Carolis, Edoardo Simonetti, et al.. (2019). S104 THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL. HemaSphere. 3(S1). 3–3. 1 indexed citations

2.

Tiacci, Enrico, Luca De Carolis, Edoardo Simonetti, et al.. (2019). THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL. Hematological Oncology. 37(S2). 110–111. 15 indexed citations

3.

Francisci, Daniela, Flavio Falcinelli, Elisabetta Schiaroli, et al.. (2012). Reactivation of Hepatitis B Virus Replication Due to Cytotoxic Therapy: A Five-Year Prospective Study. Tumori Journal. 98(2). 220–224. 7 indexed citations

4.

Francisci, Daniela, Flavio Falcinelli, Elisabetta Schiaroli, et al.. (2012). Reactivation of hepatitis B virus replication due to cytotoxic therapy: a five-year prospective study.. PubMed. 98(2). 220–4. 7 indexed citations

5.

Francisci, Daniela, Elisabetta Schiaroli, Monia Capponi, et al.. (2009). Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy. Infection. 38(1). 58–61. 47 indexed citations

6.

Tabilio, Antonio, Franca Falzetti, Tiziana Zei, et al.. (2004). Graft engineering for allogeneic haploidentical stem cell transplantation. Blood Cells Molecules and Diseases. 33(3). 274–280. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact